GenmabGMAB, on Monday, announced its plan to buy cancer-focused biotech company MerusMRUS for about $8 billion. The news sent ...

Denmark's Genmab has agreed to acquire Merus NV , a Nasdaq-listed Dutch biotech firm developing a head-and-neck cancer drug, ...

The FDA has granted fast track designation to the investigational drug CRB-701 for recurrent or metastatic head and neck ...

Review of proton re-irradiation for head and neck cancer was presented, with a focus on efficacy, safety, and future research ...

A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in ...

Head and neck cancer is a broad term for several types of cancers that include the mouth (oral cavity), throat (pharynx), voice box (larynx), sinuses and nose cavity, and salivary glands. Head and ...

March 11, 2011 (Hollywood, Florida) — Modest changes in the 2011 National Comprehensive Cancer Network (NCCN) Head and Neck Cancers Guidelines will refine and improve the treatment of these complex, ...

The Trump administration is expected to name cancer researcher Dr. Anthony Letai as the new head of its National Cancer ...

Denmark’s Genmab A/S agreed to acquire Merus NV, a Dutch drugmaker that’s developing a treatment for cancer of the head and ...